Arrowhead Research Corporation (NASDAQ: ARWR) 86% HIGHER; announced that its Calando Pharmaceuticals, Inc. subsidiary has entered into a worldwide license ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE